Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis

Clinical and Experimental Immunology

Volumn 140, Issue 2, 2005, Pages 241-248

  Ohkawara, Tatsuya ^a,b   Miyashita, K ^a   Nishihira, J ^b   Mitsuyama, K ^d   Takeda, H ^a   Kato, M ^a   Kondo, N ^b   Yamasaki, Y ^c   Sata, M ^d   Yoshiki, T ^b   Sugiyama, T ^e   Asaka, M ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GeneticLab Co   (Japan)

^c Japan Tabacco Inc Umegaoka 6 2   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Corticosterone; Dextran sulphate sodium induced colitis; Inflammatory bowel disease; Macrophage migration inhibitory factor; Neutrophil

Indexed keywords

BETA ACTIN; BETA GLOBIN; COMPLEMENTARY DNA; CORTICOSTERONE; DEXTRAN SULFATE; DRINKING WATER; GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; COLITIS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOMEGALOVIRUS; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EMBRYO; ENHANCER REGION; ENTERITIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; SURVIVAL RATE; TRANSGENIC MOUSE;

ANIMALS; COLITIS; COLON; CORTICOSTERONE; DEXTRAN SULFATE; DISEASE SUSCEPTIBILITY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; NEUTROPHIL INFILTRATION; PEROXIDASE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 20244379867     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02771.x     Document Type: Article

References (31)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-29.
2. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997; 92:S5-11.
3. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000; 51:289-98.
4. Targan SR, Hanauer SB, van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337:1029-35.
5. van Dullemen HM, van Deventer SJ, Hommes DW et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109:129-35.
6. Weiser WY, Temple PA, Witec-Giannoti JS et al. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1989; 86:7522-7.
7. Bernhagen J, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365:756-9.
8. Bucala R. MIF rediscovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 1996; 7:19-24.
9. Calandra T, Bernhagen J, Metz CN et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377:68-71.
10. Calandra T, Bernhagen J, Mitchell RA et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179:1895-902.
11. Onodera S, Tanji H, Suzuki K, Kaneda K et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999; 11:163-7.
12. Donnelly SC, Haslett C, Reid PT et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3:320-3.
13. Lan HY, Yang N, Nikolic-Paterson DJ et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000; 57:499-509.
14. Mikulowska A, Metz CN, Bucala R et al. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997; 158:5514-17.
15. Makita H, Nishimura M, Miyamoto K et al. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharade-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 1998; 158:573-9.
16. Lan HY, Bacher M, Yang N et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 1997; 185:1455-65.
17. de Jong YP, Abadia-Molina AC, Satoskar AR et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2:1061-6.
18. Ohkawara T, Nishihira J, Takeda H et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002; 123:256-70.
19. Murakami H, Akbar SMF, Matsui H et al. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001; 31:337-43.
20. Okayasu I, Hatakeyama S, Yamada M et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98:694-702.
21. Sasaki S, Nishihira J, Ishibashi T et al. Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney. Kidney Int 2004; 65:469-81.
22. Ayagi Y, Isaka Y, Akagi A et al. Transcriptional activation of a hybrid promoter composed of cytomegalovirus enhancer and β-actin/β-globin gene in glomerular epithelial cells in vivo. Kidney Int 1997; 51:1265-9.
23. Miyazaki J, Takaki S, Araki K et al. Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 1989; 79:269-77.
24. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108:193-9.
25. Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 1998; 10:199-205.
26. Cooper HS, Murthy SNS, Shah RS et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69:238-50.
27. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87:1344-50.
28. Dieleman LA, Ridwan BU, Tennyson GS et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107:1643-52.
29. Onodera S, Suzuki K, Matsuno T et al. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 1997; 92:131-7.
30. Baumann R, Casaulta C, Simon D et al. Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 2003; 17:2221-30.
31. Fingerle-Rowson G, Koch P, Bikoff R et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003; 162:47-5.